F. Demirkol Et Al. , "Developing Ondansetron Orally Disintegrated Film Formulation Under Risk Assesment Perspective ," FIP World Congress , Abu Dhabi, United Arab Emirates, pp.1, 2019
Demirkol, F. Et Al. 2019. Developing Ondansetron Orally Disintegrated Film Formulation Under Risk Assesment Perspective . FIP World Congress , (Abu Dhabi, United Arab Emirates), 1.
Demirkol, F., Mesut, B., Kalayı, M., & Aksu, B., (2019). Developing Ondansetron Orally Disintegrated Film Formulation Under Risk Assesment Perspective . FIP World Congress (pp.1). Abu Dhabi, United Arab Emirates
Demirkol, Feride Et Al. "Developing Ondansetron Orally Disintegrated Film Formulation Under Risk Assesment Perspective ," FIP World Congress, Abu Dhabi, United Arab Emirates, 2019
Demirkol, Feride Et Al. "Developing Ondansetron Orally Disintegrated Film Formulation Under Risk Assesment Perspective ." FIP World Congress , Abu Dhabi, United Arab Emirates, pp.1, 2019
Demirkol, F. Et Al. (2019) . "Developing Ondansetron Orally Disintegrated Film Formulation Under Risk Assesment Perspective ." FIP World Congress , Abu Dhabi, United Arab Emirates, p.1.
@conferencepaper{conferencepaper, author={Feride Demirkol Et Al. }, title={Developing Ondansetron Orally Disintegrated Film Formulation Under Risk Assesment Perspective }, congress name={FIP World Congress}, city={Abu Dhabi}, country={United Arab Emirates}, year={2019}, pages={1} }